In this video interview, Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at the Northwestern ...

In this video interview, Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at the Northwestern ...

Galderma Canada has announced the Health Canada authorization of NEMLUVIO (nemolizumab), a first-in-class biologic treatment for both moderate-to-severe atopic dermatitis and prurigo nodularis.

Continued strong growth of ZORYVE® (roflumilast) in 2026 with full-year net product sales guidance of $455–$470 millionAdvancement of ZORYVE ...

Two patients present with rash eruptions on different parts of the body. Can you correctly identify each case?

Scalp flaking seems harmless and picking the scabs can even be satisfying for many. However, it may signal more serious ...

Learn what collagen is, why it may or may not have benefits for psoriasis, according to experts, and what the research has found so far.

Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published in Nutrients. A recently approved injectable eczema drug provides quick ...

The Authority held that treatment of psoriasis, dermatitis, fungal infections, and similar conditions constitutes healthcare ...

If Briogeo’s dandruff shampoo is a toner for your scalp and hair, the conditioner is a moisturizer. Think of it as the ...

The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indicationsAllschwil, Switzerland - January 6, 2026 ...

Seborrheic dermatitis is positively associated with a range of epithelial barrier diseases, including dermatologic, respiratory, gastrointestinal, and ocular diseases.